Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.
about
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptideThe vitamin D-antimicrobial peptide pathway and its role in protection against infectionInhibitory Effects of Antimicrobial Peptides on Lipopolysaccharide-Induced InflammationPeptides and Peptidomimetics for Antimicrobial Drug DesignAntiviral potential of cathelicidinsMidkine in host defenceStructures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micellesDecoding the Functional Roles of Cationic Side Chains of the Major Antimicrobial Region of Human Cathelicidin LL-37High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.Oral antimicrobial peptides: Types and role in the oral cavityOn the Functional Overlap between Complement and Anti-Microbial PeptidesAntimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implicationsInteractions between neutrophil-derived antimicrobial peptides and airway epithelial cellsLow plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysisAntiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37Lactoferrin Suppresses Neutrophil Extracellular Traps Release in InflammationCationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.Collectins, H-ficolin and LL-37 reduce influence viral replication in human monocytes and modulate virus-induced cytokine production.LL-37 opsonizes and inhibits biofilm formation of Aggregatibacter actinomycetemcomitans at subbactericidal concentrations.Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules?The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growthMultivariate design and evaluation of a set of RGRPQ-derived innate immunity peptides.Oral antimicrobial peptides and biological control of cariesBacterial invasion and persistence: critical events in the pathogenesis of periodontitis?Association of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple beta-defensins in gingival keratinocytesAn enhancer peptide for membrane-disrupting antimicrobial peptides.Treponema denticola suppresses expression of human {beta}-defensin-3 in gingival epithelial cells through inhibition of the toll-like receptor 2 axisCathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo.Gene cloning, expression and characterization of avian cathelicidin orthologs, Cc-CATHs, from Coturnix coturnix.Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's diseaseSalivary antimicrobial peptide expression and dental caries experience in childrenEvidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri.Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteasesThe antimicrobial peptide LL-37 is anti-inflammatory and proapoptotic in human periodontal ligament cells.Proteolytic inactivation of LL-37 by karilysin, a novel virulence mechanism of Tannerella forsythiaDirect recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease.Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections.Lack of cathelicidin processing in Papillon-Lefèvre syndrome patients reveals essential role of LL-37 in periodontal homeostasisPapillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defensesAmniotic fluid cathelicidin in PPROM pregnancies: from proteomic discovery to assessing its potential in inflammatory complications diagnosis.
P2860
Q21090025-9894EA4F-DD7D-46CE-BEB0-5181C919EF5DQ24647840-736B403D-CBE7-4337-9B6C-633C4F21C949Q26776409-E3120C85-808B-4960-AADD-A8B4DD302F7FQ26799959-0144ECCC-6C09-47E9-AB5B-66F75B0B0418Q27006576-93CAB493-B2EE-402D-A895-F3BBDB6981DEQ27010045-3394B756-A8A3-416D-84CB-71BEB117C1B5Q27652293-62F821A0-7BC6-4567-8326-90684653BEF6Q27675567-43D57D12-588C-4D6C-995A-19BCC01D22B0Q27692605-97CA5589-03F7-4F82-9F0E-7438E5EB08E9Q28077706-0DC7ABCF-150F-4FA7-B2C1-B6AF13ED0ECAQ28082379-29026BFE-433D-4DFF-BE3A-5937E9FEDE20Q28087327-30D8450B-72FD-4F94-80CB-2F4860657528Q28297764-230C14CE-CD41-41FB-8A7A-91FA12D3A486Q28306312-4283059D-69DB-49BF-BA73-171021B94B3EQ28477585-83D31D95-8018-452E-BED1-38D211440400Q28828347-E3C099DB-BD16-4C40-8469-C83F5C50873CQ30151971-40ED1880-AAB3-42BF-9031-23E40B4729BFQ30395313-00818536-D9BE-492B-BE12-9711F8323BD0Q30555350-64398C0A-61E1-4514-9C39-5F770D616D04Q30564789-FD24E23F-3DFD-4897-82FC-9FBFA49181F4Q30933550-FE0CE248-4FB4-457F-8596-387152C5F29FQ33238927-C0C3384C-B21F-4B5D-A854-84A19CFF84ACQ33255353-F62A6479-98F6-47EC-97C7-2D899325DD0FQ33359654-CE1FB465-E2D1-4805-B8BD-39CA0D20C5CFQ33497628-36F58E5C-0D8C-4826-8200-53B0A43EF17DQ33530950-CAE66052-E7C4-405B-BE35-A50A17D58ECCQ33613845-857573DE-01D1-4D88-9423-7915EDAF0697Q33700171-E36C7EAE-2CAE-4E8B-B1E5-1CD797CB72EBQ33837370-D450C15A-80EA-4B37-8C82-F3E4993D8EA9Q33894236-1722DC3E-8DC2-47AE-813F-03B195F28643Q33935236-AEB9CC51-EB9A-4A88-B4F6-E7683E58BA9AQ33999607-2656A434-112A-4344-86F2-1620E7578284Q34044666-DDF1F10A-FE51-480C-88B0-3E55F2F57079Q34069889-D98DB56D-AECE-4C5E-BF02-EFDB0119F796Q34205244-193F4E1A-8165-467F-9488-962D5C25E663Q34211527-01A29137-EBAF-4CE1-8356-200CB520E53EQ34264486-397FD261-BA02-42B9-9E37-8DEA9208B94BQ34274507-3B9EE327-5290-42A7-BEB9-AF3AE53B6E76Q34311747-6C863070-B01B-4D81-BAB0-04B1E9492A25Q34345770-75AF919B-6684-4F95-BF49-E8284DA55C52
P2860
Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Deficiency of antibacterial pe ...... ostmann: an observation study.
@en
Deficiency of antibacterial pe ...... ostmann: an observation study.
@nl
type
label
Deficiency of antibacterial pe ...... ostmann: an observation study.
@en
Deficiency of antibacterial pe ...... ostmann: an observation study.
@nl
prefLabel
Deficiency of antibacterial pe ...... ostmann: an observation study.
@en
Deficiency of antibacterial pe ...... ostmann: an observation study.
@nl
P2093
P1433
P1476
Deficiency of antibacterial pe ...... ostmann: an observation study.
@en
P2093
Göran Carlsson
Hans G Boman
Katrin Pütsep
P304
P356
10.1016/S0140-6736(02)11201-3
P407
P577
2002-10-01T00:00:00Z